A program, aired on the TV show
'60 Minutes' February 12, 2012, reported on what could be one of the worst cases of medical research fraud in the United States. What will be the outcome? What needs to be learned from this? How can this be prevented from ever happening again? View the CBS News Interview by Scott Pelley, on the 60 minutes website, called
"Deception at Duke" [14 min.].
Labels: cancer news, cancer research, cancer treatment, cancer trials, chemotherapy, clinical trials, Dr. Anil Potti, drug trials, Duke University Medical Center, experimental treatment, medical fraud, research fraud
New Understanding of Dengue Virus Points Way to Possible Therapies for Dengue Fever NIH News ~ April 22, 2009Doctors have no specific drugs to treat dengue fever, a viral illness spread by mosquitoes that sickens 50 million to 100 million people and causes 20,000 deaths worldwide each year. Researchers have identified the cellular components in mosquitoes and in humans that dengue virus uses to multiply inside these hosts after infecting them. Scientists are hopeful that these findings could lead to the development of anti-dengue drugs.
The
National Institute of Allergy and Infectious Diseases (NIAID), part of the
National Institutes of Health, funded the research, which was led by
Mariano Garcia-Blanco MD PhD, of
Duke University Medical Center. The research appears in the current issue of the journal
Nature. Click for further information on NIAID research efforts on
dengue fever.
Labels: dengue fever, dengue virus, Duke University Medical Center, Nature, NIAID, NIH
